XYREM® Manufacturing Services and Supply Agreement Between Patheon Pharmaceuticals Inc. and Jazz Pharmaceuticals, Inc.Manufacturing Services and Supply Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS MANUFACTURING SERVICES AND SUPPLY AGREEMENT (the "Agreement") made as of the 13th day of March, 2007, and with an Effective Date and a Manufacturing Commencement Date as set forth below.
LICENSE AGREEMENT by and between SOLVAY PHARMACEUTICALS, INC. and JAZZ PHARMACEUTICALS, INC. relating to LUVOX®-IR (fluvoxamine) and LUVOX®-ER (fluvoxamine extended release) Dated January 31, 2007License Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is made and entered into as of the 31st day of January, 2007 (“Effective Date”), by and between SOLVAY PHARMACEUTICALS, INC., a Georgia corporation having its principal office at 901 Sawyer Road, Marietta, Georgia 30062 (“Solvay”) and JAZZ PHARMACEUTICALS, INC., a Delaware corporation, having its principal offices at 3180 Porter Drive, Palo Alto, California 94304 (“Jazz Pharmaceuticals”). Solvay and Jazz Pharmaceuticals are referred to herein on occasion separately as a “Party” or together as the “Parties”.
7 November 2006 ELAN CORPORATION, PLC. AND SOLVAY PHARMACEUTICALS INC. AMENDMENT AGREEMENT NO. 3 TO THE LICENCE AGREEMENT OF 22 DECEMBER 1997Licensing Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • Georgia
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
This Agreement is made the 22nd day of December 1997License Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • Georgia
• ELAN is beneficially entitled to the use of various patents, including the ELAN PATENT RIGHTS, which have been granted or are pending under the International Convention in relation to the development and production of drug specific dosage forms for pharmaceutical products and process, and
AMENDED AND RESTATED XYREM LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • New York
This AMENDED AND RESTATED LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of June 30, 2006 (“Execution Date”), by and between Jazz Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 3180 Porter Drive, Palo Alto, California 94304, USA (together with its Affiliates, “Jazz Pharmaceuticals”), and UCB Pharma Limited, a company organized under the laws of England having its principal place of business at 208 Bath Road, Slough, Berkshire, SL1 3WE (together with its Affiliates, “UCB”).
SUBLEASE AGREEMENT for 3400 Hillview Avenue, Building 2, First Floor Palo Alto, California with Jazz Pharmaceuticals, Inc.Sublease Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS SUBLEASE, dated for reference purposes the 25th day of February, 2007, by and between XEROX CORPORATION, a New York corporation, having its principal office at 800 Long Ridge Road, Stamford, Connecticut 06904 (hereinafter referred to as “Sublandlord”) and JAZZ PHARMACEUTICALS, INC., a California corporation having its principal offices at 3180 Porter Drive, Palo Alto, CA 94304 (hereinafter referred to as “Subtenant”), as a sublease under a certain Master Lease as more particularly described below.
Amendment No. 1 to Sodium Gamma Hydroxybutyrate Development and Supply AgreementSodium Gamma Hydroxybutyrate Development and Supply Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
Amendment No. 1, dated February 7, 2005 (this “Amendment”), between Orphan Medical, Inc., a Delaware corporation (“Orphan”), and Lonza, Inc., a New York corporation (“Supplier”).
ADDENDUM No. 3 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENTMaster Services Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
THIS ADDENDUM NO. 3 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENT (this “Addendum”) is entered into as of the 17th day of August, 2006 (the “Effective Date”) by and between Express Scripts Specialty Distribution Services, Inc. (“SDS”) and Jazz Pharmaceuticals, Inc.
Licence Agreement between Elan Corporation, plc and Solvay Pharmaceuticals Inc. dated 22nd December, 1997 as amended by Amendment dated 1st March, 1999 (the “Agreement”)Licence Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
Defined texts used in this letter shall have the meanings assigned to them in the Agreement unless such terms are expressly defined in this letter. All other provisions of the Agreement not amended herein shall remain unchanged and in full force and effect.
ADDENDUM No. 2 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENTMaster Services Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
This Addendum No. 2 (the “Addendum”) to the AMENDED AND RESTATED MASTER SERVICES AGREEMENT dated as of May 31, 2005, as amended (collectively, the “Agreement”), by and between EXPRESS SCRIPTS SPECIALTY DISTRIBUTION SERVICES, INC. (“ESSDS”) and ORPHAN MEDICAL, INC. (“Orphan Medical”) and assigned to JAZZ PHARMACEUTICALS, INC. (“Jazz Pharmaceuticals”), is entered into as of the 22nd day of June, 2006 (the “Effective Date”) by and between ESSDS and Jazz Pharmaceuticals. Capitalized terms not otherwise defined herein shall have the same meanings as in the Agreement.
SUPPLY AGREEMENTSupply Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Supply Agreement (the “Agreement”) is entered into as of the 31st day of January, 2007 (the “Effective Date”), by and between Jazz Pharmaceuticals, Inc., a Delaware corporation (together with its subsidiaries, “Jazz Pharmaceuticals”), and Solvay Pharmaceuticals, Inc., a Georgia corporation (“Solvay”).
ASSIGNMENT, ASSUMPTION AND CONSENTAssignment, Assumption and Consent • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • Georgia
THIS ASSIGNMENT, ASSUMPTION AND CONSENT (this “Agreement”) is dated as of January 31, 2007 (the “Effective Date”), by and among Jazz Pharmaceuticals, Inc., a Delaware corporation (“Assignee”), Solvay Pharmaceuticals, Inc., a Georgia corporation (“Assignor”) and Elan Pharma International Limited, a company incorporated in Ireland (“Elan”).
AMENDMENT NO. 3 TO XYREM SUPPLY AGREEMENTXyrem Supply Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 3 dated this 21st day of March, 2005 (this “Amendment”) to Xyrem Supply Agreement dated June 30, 2000 by and between Orphan Medical, Inc., a Delaware corporation (“ORPHAN”), and DSM Pharmaceuticals, Inc. (formerly, Catalytica Pharmaceuticals, Inc.), a Delaware corporation (“DSM”):
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Additional Services Request Form relates to and is part of the Amended and Restated Services Agreement between Express Scripts Specialty Distribution Services, Inc. and Orphan Medical, Inc. effective as of January 1, 2005.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • New York
This ASSET PURCHASE AGREEMENT (the “Agreement”) is made as of this 4th day of October, 2004 by and between Glaxo Group Limited, a company incorporated under the laws of England and Wales with offices at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN, UK (“GGL”), SmithKline Beecham Corporation, doing business as GlaxoSmithKline, a company incorporated under the laws of the Commonwealth of Pennsylvania with offices at One Franklin Plaza, 200 North 16th Street, Philadelphia, Pennsylvania 19101 U.S.A. (“SB”) (GGL and SB are collectively referred to in this Agreement as “GSK”), and Jazz Pharmaceuticals, Inc., a company incorporated under the laws of the State of Delaware with offices at 3180 Porter Drive, Palo Alto, California 94304, U.S. (“Jazz Pharmaceuticals”). GSK and Jazz Pharmaceuticals are referred to herein on occasion separately as a “Party” or together as the “Parties”.
COMMERCIAL LEASECommercial Lease • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS LEASE is entered into as of June 2, 2004 (the “Effective Date”), by and between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, a body having corporate powers under the laws of the State of California (“Landlord”), and JAZZ PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
ORPHAN MEDICAL, INC. AND CATALYTICA PHARMACEUTICALS, INC. XYREM SUPPLY AGREEMENTSupply Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • North Carolina
THIS AGREEMENT (“Agreement”) is made as of this 30th day of June, 2000 by and between ORPHAN MEDICAL, INC., a Minnesota corporation, having its principal offices at 13911 Ridgedale Drive, Minnetonka, Minnesota 55305 (“ORPHAN”) and Catalytica Pharmaceuticals, Inc., a Delaware corporation, having its principal offices at Intersection US 13/NC11 and US 264, Greenville, North Carolina 27834 (“Catalytica”).
ContractDevelopment and Supply Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • Minnesota
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
TRADEMARK LICENSE AGREEMENTTrademark License Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
AMENDMENT TO LICENSE AGREEMENTLicense Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment to the Licence Agreement (the “Amendment”) is effective as of the 1st day of March 1999 between Elan Corporation, plc and Solvay Pharmaceutical, Inc.
ContractQuality Agreement • March 27th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
